Preferred Label : Secondary Malignant Neoplasm;

NCIt related terms : secondary cancer; Secondary Malignancy; Secondary malignant neoplasm of unspecified site; SMN;

NCIt definition : A malignant neoplasm that arises from a pre-existing lower grade lesion, or as a result of a primary lesion that has spread to secondary sites, or due to a complication of a cancer treatment.;

Alternative definition : NCI-GLOSS: A term that is used to describe either a new primary cancer or cancer that has spread from the place in which it started to other parts of the body.;

Neoplastic status : Malignant;

NCI Metathesaurus CUI : CL524172;

Codes from synonyms : CDR0000044457; C79.9;

Details


Main resources

You can consult :


https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.